Description
-
What is RenehaVis?
RenehaVis is a sodium hyaluronate product comprising a dual-chambered prefilled syringe that enables administration of both high- and low-molecular-weight hyaluronate in a single intra-articular injection. Using high and low molecular weight sodium hyaluronate improves both cushioning and elasticity, enabling improvement in movement and pain relief at rest and during activity. RenehaVis
RenehaVis is a product designed to relieve pain and stiffness of the knee joint in patients with degenerative changes to the synovial joint, including osteoarthritis. RenehaVis contains 2 different Hyaluronic Acids with 2 different concentrations in 1 syringe, either 15.4mg/0.7ml or 7.0mg/0.7ml.
How RenehaVis Works
The prefilled, dual-chamber syringe administers two types of sodium hyaluronate in a single procedure:- First Chamber: Contains a low-molecular-weight (LMW) hyaluronic acid with a water-like consistency, which helps to lubricate the joint and provide rapid pain relief.
- Second Chamber: Contains a high-molecular-weight (HMW) hyaluronic acid with a gel-like consistency. This acts as a shock absorber and provides long-term cushioning for the cartilage.
Treatment & Administration- Course of treatment: Typically, a standard course involves one intra-articular injection per week for up to three weeks, depending on the severity of the osteoarthritis.
- Duration of effect: Clinical studies demonstrate that symptom relief can last for up to 4 to 12 months, depending on the patient’s condition.
- Side effects: Common local reactions can include temporary pain, swelling, redness, or stiffness at the injection site.
